Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Lower-risk profile A 45-year-old on amlodipine 2.5 mg with a well-controlled BP of 140/85 mmHg, no other medications, and no CYP3A4 inhibitors in their regimen faces a meaningfully smaller risk from 100 to 250 mg/day of resveratrol than the high-risk profile above
Chen, H., Sullivan, G
The cost is almost nothing
Among Americans who have never taken GLP-1s but are considering beginning treatment in the next 12 months, 25.1% cite the pill option as the primary factor influencing their desire to begin treatment, and among the 9.3% of Americans who have discontinued GLP-1 treatments, 44.1% say they are considering resuming treatments because of pill options
US$ 21.02
US$ 28.23
US$ 28.95
